Traumatic intracranial hemorrhage in patients taking dabigatran: Report of 3 cases and review of the literature

Neurosurgery

Volumn 73, Issue 2, 2013, Pages

  Wassef, Shafik N ^a   Abel, Taylor J ^a   Grossbach, Andrew ^a   Viljoen, Stephanus V ^a   Jackson, Adam W ^a   Howard III, Matthew A ^a   Greenlee, Jeremy D W ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Anticoagulation; Dabigatran; Intracranial hemorrhage; Paradaxa; Traumatic brain injury

Indexed keywords

ACETYLSALICYLIC ACID; DABIGATRAN; ETIRACETAM; FRESH FROZEN PLASMA;

AGED; ANTICOAGULANT THERAPY; ARM WEAKNESS; ARTICLE; BRAIN HEMORRHAGE; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMATOSE PATIENT; COMPUTER ASSISTED TOMOGRAPHY; DECOMPRESSION SURGERY; DRUG WITHDRAWAL; DYSARTHRIA; EXTUBATION; FALLING; FEMALE; FOLLOW UP; FRONTAL LOBE; HEAD INJURY; HEART ATRIUM FIBRILLATION; HUMAN; INJURY SEVERITY; INTERNATIONAL NORMALIZED RATIO; MALE; NEUROIMAGING; NEUROSURGERY; PARIETAL LOBE; PRIORITY JOURNAL; RESPIRATORY TRACT INTUBATION; SEIZURE; SPEECH DISORDER; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SURGICAL DRAINAGE; TRAUMATIC BRAIN INJURY;

ACCIDENTAL FALLS; AGED; ANTITHROMBINS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; CRANIOCEREBRAL TRAUMA; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE;

EID: 84880922979     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000430763.95349.5f     Document Type: Article

References (26)

1. Alberts MJ, Bernstein RA, Naccarelli GV, Garcia DA. Using dabigatran in patients with stroke: a practical guide for clinicians. Stroke. 2012;43(1):271-279.
2. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139-1151.
3. Hart RG, Diener HC, Yang S, et al. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke. 2012;43(6):1511-1517.
4. Lavoie A, Ratte S, Clas D, et al. Preinjury warfarin use among elderly patients with closed head injuries in a trauma center. J Trauma. 2004;56(4):802-807.
5. Dossett LA, Riesel JN, Griffin MR, Cotton BA. Prevalence and implications of preinjury warfarin use: an analysis of the National Trauma Databank. Arch Surg. 2011;146(5):565-570.
6. Dowlatshahi D, Butcher KS, Asdaghi N, et al. Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal. Stroke. 2012; 43(7):1812-1817.
7. Cotton BA, McCarthy JJ, Holcomb JB. Acutely injured patients on dabigatran. N Engl J Med. 2011;365(21):2039-2040.
8. Garber ST, Sivakumar W, Schmidt RH. Neurosurgical complications of direct thrombin inhibitors\catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran. J Neurosurg. 2012;116(5):1093-1096.
9. Stangier J, Stähle H, Rathgen K, Fuhr R. Pharmacokinetics and pharmacody-namics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects. Clin Pharmacokinet. 2008;47(1):47-59.
10. Hankey GJ, Eikelboom JW. Dabigatran etexilate: a new oral thrombin inhibitor. Circulation. 2011;123(13):1436-1450.
11. DiNicolantonio JJ. Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial. Expert Opin Pharmacother. 2012;13 (8):1101-1111.
12. Chang EF, Meeker M, Holland MC. Acute traumatic intraparenchymal hemorrhage: risk factors for progression in the early post-injury period. Neurosurgery. 2006;58(4):647-656; discussion 647-656.
13. Alahmadi H, Vachhrajani S, Cusimano MD. The natural history of brain contusion: an analysis of radiological and clinical progression. J Neurosurg. 2010; 112(5):1139-1145.
14. Rockswold GL, Leonard PR, Nagib MG. Analysis of management in thirty-three closed head injury patients who "talked and deteriorated" Neurosurgery. 1987;21 (1):51-55.
15. Batchelor JS, Grayson A. A meta-analysis to determine the effect of anticoagulation on mortality in patients with blunt head trauma. Br J Neurosurg. 2012;26(4): 525-530.
16. Li J, Brown J, Levine M. Mild head injury, anticoagulants, and risk of intracranial injury. Lancet. 2001;357(9258):771-772.
17. Wintzen AR, Tijssen JG. Subdural hematoma and oral anticoagulant therapy. Arch Neurol. 1982;39(2):69-72.
18. Stangier J, Rathgen K, Stähle H, Mazur D. Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clin Pharmacokinet. 2010;49(4):259-268.
19. van Ryn J, Stangier J, Haertter S, et al. Dabigatran etexilate\a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost. 2010;103(6):1116-1127.
20. Van Ryn RD, Priepke H, et al. Reversibility of the anticoagulant effect of high doses of the direct thrombin inhibitor dabigatran, by recombinant Factor VIIa or activated prothrombin complex concentrate. Haematologica. 2008;93(suppl 1):148.
21. Oh JJ, Akers WS, Lewis D, Ramaiah C, Flynn JD. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin. Pharmacotherapy. 2006;26(4):569-577.
22. Wanek MR, Horn ET, Elapavaluru S, Baroody SC, Sokos G. Safe use of hemodialysis for dabigatran removal before cardiac surgery. Ann Pharmacother. 2012;46(9):e21.
23. Wychowski MK, Kouides PA. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment. Ann Pharmacother. 2012;46(4):e10.
24. Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW. Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood. 2012;119(9):2172- 2174.
25. Cano EL, Miyares MA. Clinical challenges in a patient with dabigatran-induced fatal hemorrhage. Am J Geriatr Pharmacother. 2012;10(2):160-163.
26. Van Ryn JLT, Waterman A, et al. Dabigatran anticoagulant activity is neutralized by an antibody selective to dabigatran in vitro and in vivo models free. J Am Coll Cardiol. 2011;57(14 suppl 1):3.